Analyst Ratings for Cellectis (CLLS)
CLLS Rating Summary
CLLS Price Target Summary
- Highest: $9.00 (Clear Street)
- Lowest: $1.30 (Barclays)
- Average: $5.66
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$5.66 (+444.2%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 62%
Avg. $ Target:
$5.66 (+444.2%)
* Over Last 12-Mos
Rating Score: 5.9 / 10
Percentile Rank: 62%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/16/2026 | Barclays | Lukas Shumway | Downgrade | Underweight (Overweight) |
1.30 (9.00) |
1.83 (1.04) |
-43.17% | Details |
| 9/15/2026 | Citizens | Silvan Tuerkcan | Downgrade | Market Perform (Market Outperform) |
N/A (N/A) |
3.10 (1.04) |
-66.45% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
